Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia
- PMID: 22927505
- PMCID: PMC3529594
- DOI: 10.1093/jnci/djs344
Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia
Abstract
Background: Treatment of acute lymphoblastic leukemia (ALL) has included the use of prophylactic cranial irradiation in up to 20% of children with high-risk disease despite known cognitive risks of this treatment modality.
Methods: Patients enrolled on the St Jude ALL Total Therapy Study XV, which omitted prophylactic cranial irradiation in all patients, were assessed 120 weeks after completion of consolidation therapy (n = 243) using a comprehensive cognitive battery. χ(2) analysis was used to compare the percentage of below-average performers among the entire ALL patient group to the expected rate based on the normative sample. Univariate logistic regression was used to estimate the effect of intensity of chemotherapy (treatment arm), age at diagnosis, and sex on the probability of below-average performance. All statistical tests were two-sided.
Results: Overall, the ALL group had a statistically significantly higher risk for below-average performance on a measure of sustained attention (67.31% more than 1 SD below the normative mean for omission errors, P < .001) but not on measures of intellectual functioning, academic skills, or memory. Patients given higher intensity chemotherapy were at greater risk for below-average performance compared with those given lower intensity therapy on measures of processing speed (27.14% vs 6.25%, P = .009) and academic abilities (Math Reasoning: 18.60% vs 3.90%, P = .008; Word Reading: 20.00% vs 2.60%, P = .007; Spelling: 27.91% vs 3.90%, P = .001) and had higher parent-reported hyperactivity (23.00% vs 9.84%, P = .018) and learning problems (35.00% vs 16.39%, P = .005). Neither age at diagnosis nor sex was associated with risk for below-average cognitive performance.
Conclusions: Omitting cranial irradiation may help preserve global cognitive abilities, but treatment with chemotherapy alone is not without risks. Caregiver education and development of interventions should address both early attention deficits and cognitive late effects.
Figures



Similar articles
-
Pediatric acute lymphoblastic leukemia: redefining outcomes.J Pediatr Hematol Oncol. 2002 Feb;24(2):88. doi: 10.1097/00043426-200202000-00005. J Pediatr Hematol Oncol. 2002. PMID: 11990711 No abstract available.
-
Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.J Clin Oncol. 2016 Apr 10;34(11):1239-47. doi: 10.1200/JCO.2015.64.3205. Epub 2016 Feb 8. J Clin Oncol. 2016. PMID: 26858334 Free PMC article.
-
Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.J Pediatr Hematol Oncol. 2000 May-Jun;22(3):206-13. doi: 10.1097/00043426-200005000-00004. J Pediatr Hematol Oncol. 2000. PMID: 10864051 Clinical Trial.
-
[Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].Med Wieku Rozwoj. 2012 Apr-Jun;16(2):128-37. Med Wieku Rozwoj. 2012. PMID: 22971657 Review. Polish.
-
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.Int J Hematol. 2001 Apr;73(3):369-77. doi: 10.1007/BF02981964. Int J Hematol. 2001. PMID: 11345205 Review.
Cited by
-
The Impact of Intensified CNS-Directed Therapy on Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation.J Clin Oncol. 2022 Dec 20;40(36):4218-4227. doi: 10.1200/JCO.22.00263. Epub 2022 Nov 2. J Clin Oncol. 2022. PMID: 36322880 Free PMC article.
-
The Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) revised: item response analysis and concurrent validity.Neuropsychology. 2015 Jan;29(1):31-44. doi: 10.1037/neu0000095. Epub 2014 Jun 16. Neuropsychology. 2015. PMID: 24933482 Free PMC article.
-
Cognitive outcomes among Latino survivors of childhood acute lymphoblastic leukemia and lymphoma: A cross-sectional cohort study using culturally competent, performance-based assessment.Pediatr Blood Cancer. 2018 Feb;65(2):10.1002/pbc.26844. doi: 10.1002/pbc.26844. Epub 2017 Oct 8. Pediatr Blood Cancer. 2018. PMID: 28988412 Free PMC article. Clinical Trial.
-
Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.Neurosci Biobehav Rev. 2015 Jun;53:108-20. doi: 10.1016/j.neubiorev.2015.03.016. Epub 2015 Apr 7. Neurosci Biobehav Rev. 2015. PMID: 25857254 Free PMC article.
-
Disruption of the Corticospinal Tract in Patients with Acute Lymphoblastic Leukemia: A Case Series.Children (Basel). 2022 Aug 12;9(8):1223. doi: 10.3390/children9081223. Children (Basel). 2022. PMID: 36010113 Free PMC article.
References
-
- Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL_BFM 95 Blood. 2008;111(9):4477–4489 - PubMed
-
- Pui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children’s Research Hospital Blood. 2004;104(9):2690–2696 - PubMed
-
- Copeland DR, Fletcher JM, Pfefferbaum-Levine B, et al. Neuropsychological sequelae of childhood cancer in long-term survivors Pediatrics. 1985;75:745–753 - PubMed
-
- Rowland JH, Glidewell OJ, Sibley RF, et al. Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia J Clin Oncol. 1984;2(12):1327–1335 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical